{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T12:50:48Z","timestamp":1758199848358,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.atherosclerosis.2007.09.017","type":"journal-article","created":{"date-parts":[[2007,11,27]],"date-time":"2007-11-27T09:20:11Z","timestamp":1196155211000},"page":"145-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia"],"prefix":"10.1016","volume":"198","author":[{"given":"Livia","family":"Pisciotta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Bellocchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Fresa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Borrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiano","family":"Calandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/01.ATV.12.7.843","article-title":"In vivo metabolism of apolipoprotein A-I in a patient with homozygous familial hypercholesterolemia","volume":"12","author":"Schaefer","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib2","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0022-2275(20)33394-0","article-title":"Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: a stable isotope study","volume":"40","author":"Frenais","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.ATV.14.5.679","article-title":"Preferential cholesteryl ester acceptors among the LDL subspecies of subjects with familial hypercholesterolemia","volume":"14","author":"Guerin","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib4","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/01.ATV.15.9.1359","article-title":"Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia","volume":"15","author":"Guerin","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0009-8981(99)00098-4","article-title":"HDL metabolism in hypertriglyceridemic states: an overview","volume":"286","author":"Lamarche","year":"1999","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib6","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/01.CIR.0000130646.93255.86","article-title":"Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study","volume":"109","author":"Veerkamp","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/hq0302.105374","article-title":"Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation","volume":"22","author":"Rashid","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib8","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1194\/jlr.M300069-JLR200","article-title":"Determinants of low HDL levels in familial combined hyperlipidemia","volume":"44","author":"Soro","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib9","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1194\/jlr.M500212-JLR200","article-title":"Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile","volume":"46","author":"van der Vleuten","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0021-9150(03)00020-0","article-title":"Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency","volume":"167","author":"Pisciotta","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib11","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2004.06.070","article-title":"A novel ApoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease","volume":"44","author":"Hovingh","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2003.09.024","article-title":"A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease","volume":"172","author":"Ikewaki","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.atherosclerosis.2005.05.028","article-title":"A novel nonsense apolipoprotein A-I mutation (apoA-IE136X) cause low HDL cholesterol in French Canadians","volume":"185","author":"Dastani","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib14","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/ATVBAHA.106.137646","article-title":"Genetic etiology of isolated low HDL syndrome. Incidence and heterogeneity of effux defects","volume":"27","author":"Kiss","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib15","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1161\/01.ATV.0000175751.30616.13","article-title":"The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes. A comprehensive study of molecular and biochemical finding in 13 unrelated Italian families","volume":"25","author":"Calabresi","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"year":"1989","author":"Sambrook","series-title":"Molecular cloning: a laboratory manual","key":"10.1016\/j.atherosclerosis.2007.09.017_bib16"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib17","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1161\/01.ATV.16.12.1416","article-title":"A cysteine-containing truncated Apo A-I variant associated with HDL deficiency","volume":"16","author":"Moriyama","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2005.08.015","article-title":"Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia","volume":"186","author":"Pisciotta","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.ATV.0000153087.36428.dd","article-title":"Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia","volume":"25","author":"Priore Oliva","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.CIR.0000081777.17879.85","article-title":"Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia","volume":"108","author":"Hopkins","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.RES.0000124922.61830.F0","article-title":"Association of Apolipoprotein A1\/C3\/A4\/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia","volume":"94","author":"Mar","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbadis.2006.10.012","article-title":"Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia","volume":"1772","author":"van der Vleuten","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib23","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1093\/hmg\/11.24.3031","article-title":"Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels","volume":"11","author":"Pennacchio","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib24","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1093\/hmg\/11.24.3039","article-title":"Relative contribution of variation within the APOC3\/A4\/A5 gene cluster in determining plasma triglycerides","volume":"11","author":"Talmud","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib25","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1194\/jlr.M400192-JLR200","article-title":"Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study","volume":"45","author":"Lai","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MOL.0b013e32803dbdd6","article-title":"Genetic factors affecting HDL levels, structure, metabolism and function","volume":"18","author":"Sviridov","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-2275(20)30194-2","article-title":"ApoA-IMALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia","volume":"43","author":"Martin-Campos","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib28","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1172\/JCI116830","article-title":"High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene","volume":"92","author":"Lackner","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib29","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1161\/01.ATV.14.12.1915","article-title":"A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas","volume":"14","author":"R\u00f6mling","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib30","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/01.ATV.15.11.1866","article-title":"A new case of ApoA-I deficiency showing codon 8 nonsense mutation of the ApoA-I gene without evidence of coronary heart disease","volume":"15","author":"Takata","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib31","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1161\/01.ATV.15.12.2157","article-title":"Apolipoprotein A-I deficiency. Biochemical and metabolic characteristics","volume":"15","author":"Ng","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/01.ATV.17.1.83","article-title":"Apolipoprotein A-IFin. Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene","volume":"17","author":"Miettinen","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0021-9150(00)00555-4","article-title":"Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-IZaragoza (L144R)","volume":"154","author":"Recalde","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib34","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/jmg.37.9.713","article-title":"I705 variant in the low density lipoprotein receptor gene has no effect on plasma cholesterol levels","volume":"37","author":"Heath","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib35","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1101\/gr.3313405","article-title":"Mutation scanning by meltMADGE: validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population","volume":"15","author":"Alharbi","year":"2005","journal-title":"Genome Res"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2003.11.009","article-title":"Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders","volume":"172","author":"Pisciotta","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.09.017_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2005.01.048","article-title":"Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes","volume":"182","author":"Pisciotta","year":"2005","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007005503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007005503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:30:07Z","timestamp":1758155407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915007005503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0021915007005503"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.09.017","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}